LILLIE JAMES E - 14 Feb 2025 Form 3 Insider Report for ACUREN CORP (TIC)

Role
Director
Signature
/s/ Fiona Sutherland, Attorney-in-Fact
Issuer symbol
TIC
Transactions as of
14 Feb 2025
Transactions value $
$0
Form type
3
Filing time
14 Feb 2025, 16:30:14 UTC
Previous filing
03 Jan 2025
Next filing
05 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TIC Common Stock 1,746,169 14 Feb 2025 By Mariposa Acquisition IX, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TIC Restricted Stock Units 14 Feb 2025 Common Stock 10,000 Direct F2, F3
holding TIC Series A Preferred Stock 14 Feb 2025 Common Stock 92,500 By Mariposa Acquisition IX, LLC F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mariposa Acquisition IX, LLC directly holds (i) 18,877,500 shares of Common Stock and (ii) 1,000,000 shares of Series A Preferred Stock convertible into shares of Common Stock for no additional consideration as set forth below. Mr. Lillie holds a limited liability company interest in Mariposa Acquisition IX, LLC and, as a result, may be deemed to have a pecuniary interest in approximately (i) 1,746,169 shares of Common Stock and (ii) 92,500 shares of Common Stock issuable upon conversion of the Series A Preferred Stock held by Mariposa Acquisition IX, LLC. Mr. Lillie disclaims beneficial ownership of the shares of Common Stock and Series A Preferred Stock held directly by Mariposa Acquisition IX, LLC except to the extent of his pecuniary interest therein. Mr. Lillie does not have beneficial ownership over the shares of Common Stock and Series A Preferred Stock held directly by Mariposa Acquisition IX, LLC.
F2 These restricted stock units vest on July 30, 2025 (the one-year anniversary of the grant date).
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock upon the earlier of (i) immediately following the "change of control dividend date" (as defined in the Issuer's certificate of incorporation) and (ii) December 31, 2034.

Remarks:

See Exhibit 24.1 - Power of Attorney